Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082158 · ClinicalTrials.gov registry record · NA
Assessment of Novel Respiratory Protective Devices in Healthcare
A NA study of Tolerability and Comfort, sponsored by National Center for Occupational Health and Infection Control.
- Completed
- Registry status
- NA
- Development phase
- 382
- Enrollment target
- 1
- Study location
NCT02082158 is a NA study of Tolerability and Comfort that has completed, run by National Center for Occupational Health and Infection Control. The registered enrollment target is 382 participants, above the 119-participant average among 4 other Tolerability trials with a reported enrollment target (221% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02082158, a NA study of Tolerability and Comfort, has completed, sponsored by National Center for Occupational Health and Infection Control.
- COMPLETED
- Registry status
- NA
- Development phase
- 382 participants
- Enrollment target
- 1
- Study location
Study Summary
This VA-based study will obtain feedback from healthcare workers via validated survey instrument on the comfort and tolerability of wearing current models of N95 respirators and novel respirator designs currently in development. There will be 4 novel respirators and 1 commonly used respirator (not locally used) to compare to a locally used respirator, which is familiar to participants. Comparisons will be examined between each of the first 5 models with the locally used control using Dunnett's t-test.
Conditions Studied
Interventions
- OTHER Study Procedures
Study Locations (1)
Florida
- Malcom Randall VA Medical Center - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 382 participants |
| Start Date | 2014-07 |
| Est. Completion | 2015-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02082158
The ClinicalTrials.gov registry entry for NCT02082158 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 382 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 119-participant average among 4 other Tolerability trials with a reported enrollment target (221% higher). The listed sponsor is National Center for Occupational Health and Infection Control, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tolerability appearing as the primary indexed condition, and to 1 intervention - of which Study Procedures is the first listed.
NCT02082158 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT02082158 about?
NCT02082158 is a clinical study titled "Assessment of Novel Respiratory Protective Devices in Healthcare". This VA-based study will obtain feedback from healthcare workers via validated survey instrument on the comfort and tolerability of wearing current models of N95 respirators and novel respirator designs currently in development. There will be 4 novel respirators and 1 commonly used respirator (not l...
What is the current status of trial NCT02082158?
This trial is currently completed. It is a NA study. The enrollment target is 382 participants. The study started on 2014-07. Estimated completion is 2015-05.
What conditions does trial NCT02082158 study?
This clinical trial studies the following conditions: Tolerability, Comfort.
What interventions are being tested in trial NCT02082158?
The interventions under investigation include: Study Procedures (OTHER).
Who is sponsoring clinical trial NCT02082158?
This trial is sponsored by National Center for Occupational Health and Infection Control, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02082158 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tolerability
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study to Test the Effects of Nezavist at Different Doses in Healthy Adults
ACTIVE NOT RECRUITING · Phase 1
-
Study to Investigate Single Ascending Oral Doses of AZD5213 in Healthy Male and Non Fertile Female Subjects
COMPLETED · Phase 1
-
Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.